Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lurasidone in children and adolescents with irritability associated with autistic disorder
NCT01911442Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Aug 2013
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lurasidone in Autism Spectrum Disorder (ASD), sponsored by Sumitomo Pharma America. Started Aug 2013; status: completed.
02
Drugs
lurasidone
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT01911442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01911442.